Danaher Corporation $DHR Stake Lifted by Mayflower Financial Advisors LLC

Mayflower Financial Advisors LLC increased its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 2.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,912 shares of the conglomerate’s stock after buying an additional 66 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in Danaher were worth $575,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Fire Capital Management LLC grew its stake in Danaher by 4.6% during the 2nd quarter. Fire Capital Management LLC now owns 3,935 shares of the conglomerate’s stock worth $777,000 after buying an additional 174 shares during the last quarter. Mendel Money Management grew its stake in Danaher by 1.7% during the 2nd quarter. Mendel Money Management now owns 23,156 shares of the conglomerate’s stock worth $4,574,000 after buying an additional 378 shares during the last quarter. Austin Private Wealth LLC grew its stake in Danaher by 4.1% during the 2nd quarter. Austin Private Wealth LLC now owns 1,930 shares of the conglomerate’s stock worth $381,000 after buying an additional 76 shares during the last quarter. New York Life Investment Management LLC grew its stake in Danaher by 1.2% during the 2nd quarter. New York Life Investment Management LLC now owns 86,821 shares of the conglomerate’s stock worth $17,151,000 after buying an additional 1,061 shares during the last quarter. Finally, Boyd Watterson Asset Management LLC OH grew its stake in shares of Danaher by 2.1% in the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after purchasing an additional 51 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on DHR. Bank of America decreased their price target on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft increased their price target on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Finally, Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Get Our Latest Analysis on Danaher

Danaher Trading Down 1.3%

Shares of DHR stock opened at $213.99 on Thursday. The stock has a 50-day simple moving average of $203.12 and a 200 day simple moving average of $199.20. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The stock has a market capitalization of $151.15 billion, a P/E ratio of 44.12, a P/E/G ratio of 3.32 and a beta of 0.77. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the business posted $1.71 earnings per share. Danaher’s revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio is currently 26.39%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.